版本:
中国

BRIEF-Endocyte presents data on two lead clinical programs at European society

Oct 10 Endocyte Inc :

* Endocyte presents data on two lead clinical programs at european society for medical oncology (ESMO) 2016 congress

* Endocyte Inc - both EC1456 and EC1169 have shown anti-tumor activity during dose escalation phase of their respective trials

* Endocyte Inc says EC1169 was well tolerated without causing dose-limiting Hematologic toxicity frequently associated with traditional chemotherapy Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐